Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic assisted calcium electroporation in esophageal cancer – safety study
2020-005787-58Phase 2Completed
- Sponsor
- Michael Patrick
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of calcium gluconate and calcium chloride in esophageal cancer, sponsored by Michael Patrick. Primary endpoint: Safety of calcium electroporation. Started Dec 2020; status: completed.
02
Drugs
calcium gluconatecalcium chloride
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2020-005787-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005787-58.